Cargando…

Ascites re-compensation in HBV-related first decompensated cirrhosis after anti-viral therapy

Effective antiviral therapy can significantly improve the long-term prognosis of HBV-related decompensated patients, and re-compensation may be achieved in part of the patients. To explore the re-compensation of ascites after HBV suppression and the risk factors, the clinical outcomes of 196 consecu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Li, Mingyu, Zong, Zheng, Xiong, Xinmiao, Fan, Jing, Zhong, Huan, Liu, Na, Ye, Wei, Jing, Jisheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Cellular and Infection Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9878306/ https://www.ncbi.nlm.nih.gov/pubmed/36710977 http://dx.doi.org/10.3389/fcimb.2022.1053608

Ejemplares similares

Ascitic Bacterial Composition Is Associated With Clinical Outcomes in Cirrhotic Patients With Culture-Negative and Non-neutrocytic Ascites
por: Chen, Yanfei, et al.
Publicado: (2018)

A novel prognostic model for predicting the risk of first variceal hemorrhage in patients with HBV-related cirrhosis
por: Zhang, Qun, et al.
Publicado: (2023)

Risk of further decompensation/mortality in patients with cirrhosis and ascites as the first single decompensation event
por: Balcar, Lorenz, et al.
Publicado: (2022)

Incidence and predictors of HBV functional cure in patients with HIV/HBV coinfection: A retrospective cohort study
por: Zhang, Qingrong, et al.
Publicado: (2023)

The Hepatitis B Surface Antigen Binding Protein: An Immunoglobulin G Constant Region-Like Protein That Interacts With HBV Envelop Proteins and Mediates HBV Entry
por: Sun, Yeping, et al.
Publicado: (2018)

Serum potassium levels and prognosis in HBV‐associated decompensated cirrhosis
por: Huang, JianJiang, et al.
Publicado: (2021)

Editorial: Drug Re-purposing for the Treatment of Bacterial and Viral Infections
por: García-Contreras, Rodolfo, et al.
Publicado: (2019)

Serum liver fibrosis markers predict hepatic decompensation in compensated cirrhosis
por: Chen, Qingling, et al.
Publicado: (2023)

High-sensitivity HBV DNA test for the diagnosis of occult HBV infection: commonly used but not reliable
por: Wang, Chengwei, et al.
Publicado: (2023)

Neutrophil count to albumin ratio as a prognostic indicator for HBV‐associated decompensated cirrhosis
por: Han, Zhong, et al.
Publicado: (2021)

Serum Cystatin C Predicts Mortality in HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2019)

Prognostic value of albumin‐related ratios in HBV‐associated decompensated cirrhosis
por: Zhang, Tan, et al.
Publicado: (2022)

SACRED: Effect of simvastatin on hepatic decompensation and death in subjects with high-risk compensated cirrhosis: Statins and Cirrhosis: Reducing Events of Decompensation
por: Kaplan, David E., et al.
Publicado: (2021)

The progress of molecules and strategies for the treatment of HBV infection
por: Pan, Youlu, et al.
Publicado: (2023)

Predictors of Refractory Ascites Development in Patients with Hepatitis B Virus-Related Cirrhosis Hospitalized to Control Ascitic Decompensation
por: Seo, Ju Hee, et al.
Publicado: (2013)

Pregnancy Is Not Associated with an Increased Risk of Decompensation, Transplant, or Death in Compensated Cirrhosis
por: Mullin, Monica, et al.
Publicado: (2022)

Diverse Effects of the NTCP p.Ser267Phe Variant on Disease Progression During Chronic HBV Infection and on HBV preS1 Variability
por: Yang, Fangji, et al.
Publicado: (2019)

Plasma D-dimer as a novel biomarker for predicting poor outcomes in HBV-related decompensated cirrhosis
por: Zhou, Jing, et al.
Publicado: (2019)

Liver-to-Spleen Volume Ratio Automatically Measured on CT Predicts Decompensation in Patients with B Viral Compensated Cirrhosis
por: Kwon, Ji Hye, et al.
Publicado: (2021)

Re-burying Artificially Exposed Surface of Viral Subunit Vaccines Through Oligomerization Enhances Vaccine Efficacy
por: Han, Xuelian, et al.
Publicado: (2022)

HBV reactivation and its effect on survival in HBV-related hepatocarcinoma patients undergoing transarterial chemoembolization combined with tyrosine kinase inhibitors plus immune checkpoint inhibitors
por: Shen, Jiaming, et al.
Publicado: (2023)

Evaluation of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Decompensated Cirrhosis With Ascites
por: Stotts, Matthew J, et al.
Publicado: (2021)

Role of precipitants in transition of acute decompensation to acute-on-chronic liver failure in patients with HBV-related cirrhosis
por: Wang, Tongyu, et al.
Publicado: (2022)

Validation of the albumin-bilirubin score for identifying decompensation risk in patients with compensated cirrhosis
por: Navadurong, Huttakan, et al.
Publicado: (2023)

Risk of Hepatocellular Carcinoma Remains High in Patients with HBV-Related Decompensated Cirrhosis and Long-Term Antiviral Therapy
por: Zhu, Dong-Mei, et al.
Publicado: (2020)

Neutrophil-to-Lymphocyte Ratio Predicts Early Mortality in Patients with HBV-Related Decompensated Cirrhosis
por: Zhang, Honggang, et al.
Publicado: (2016)

Culture-Positive Spontaneous Ascitic Infection in Patients with Acute Decompensated Cirrhosis: Multidrug-Resistant Pathogens and Antibiotic Strategies
por: Liu, Jing, et al.
Publicado: (2020)

Absolute quantification of microparticles by flow cytometry in ascites of patients with decompensated cirrhosis: a cohort study
por: Engelmann, Cornelius, et al.
Publicado: (2017)

Frequency, characteristics and impact of multiple consecutive nosocomial infections in patients with decompensated liver cirrhosis and ascites
por: Schultalbers, Marie, et al.
Publicado: (2020)

The value of ascitic neutrophil gelatinase‐associated lipocalin in decompensated liver cirrhosis with spontaneous bacterial peritonitis
por: Liu, Hua, et al.
Publicado: (2020)

The value of next-generation metagenomic sequencing in pathogen detection of pleural effusions and ascites from children with sepsis
por: Liu, Gang, et al.
Publicado: (2023)

Current State and Progress of Research on the Role of lncRNA in HBV-Related Liver Cancer
por: Wang, Xueke, et al.
Publicado: (2021)

The Role of Autophagy in the Mother-to-Child Transmission of Pregnant Women With a High Level of HBV DNA
por: Gao, Hong, et al.
Publicado: (2022)

Platelet‐to‐white blood cell ratio: A novel and promising prognostic marker for HBV‐associated decompensated cirrhosis
por: Zhang, JinFei, et al.
Publicado: (2020)

Six-minute walk test predicts future decompensation in patients with compensated liver cirrhosis
por: Henrique, Diane Michela Nery, et al.
Publicado: (2022)

Mean Platelet Volume/Lymphocyte Ratio as a Prognostic Indicator for HBV-Related Decompensated Cirrhosis
por: Wu, JianPing, et al.
Publicado: (2020)

Staphylococcus cohnii infection diagnosed by metagenomic next generation sequencing in a patient on hemodialysis with cirrhotic ascites: a case report
por: Lei, Yu, et al.
Publicado: (2023)

Ascites and Cirrhosis
por: Stott, Hugh
Publicado: (1911)

Alterations in the gut microbiota and the efficacy of adjuvant probiotic therapy in liver cirrhosis
por: Wu, Zengrong, et al.
Publicado: (2023)

Ascites’ neutrophil function is significantly impaired in patients with decompensated cirrhosis but can be restored by autologous plasma incubation
por: Engelmann, Cornelius, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_v6rdbjd4tjnoj7q1mgk73is4do